Senseonics Holdings (SENS) Announces FDA Approval of World's First Long-Term Implantable Continuous Glucose Monitoring System

June 21, 2018 3:15 PM EDT Send to a Friend
Senseonics Holdings, Inc. (NYSE: SENS) today announced the U.S. Food and Drug Administration has approved its Premarket Approval (PMA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login